Starwin Products

Starwin Products originated in 1960 as the Ghanaian branch of Sterling Products International. Its early development took place during a period when Ghana was building local industrial capacity and expanding domestic participation in manufacturing. In 1976, as part of the Ghanaian government's indigenization program, half of the company's stock was sold to Ghanaian entrepreneurs. This transaction shifted a substantial portion of ownership toward local investors while retaining the company's connection to the Sterling organization. A further corporate change occurred in 1987, when Sterling Products International was acquired by Kodak. After that transaction, Starwin Products emerged as a Ghanaian pharmaceutical company operating under its own name. The company manufactured branded pharmaceutical products for the Ghanaian market. Available descriptions identify eight brand-name products in its portfolio, including Rapinol, Asmadrin, Painoff, Paraking, milk of magnesia, and liver salts. The available reference material does not identify the remaining products or provide detailed information about manufacturing sites, sales volumes, or export activity. Starwin's corporate significance increased in the early 2000s. On January 13, 2004, it became a public limited liability company. In December of the same year, it was admitted to trading on the Ghana Stock Exchange. It was described as the first pharmaceutical company to be listed on the exchange and was included in the GSE All-Share Index. The listing positioned Starwin at the intersection of Ghana's pharmaceutical manufacturing sector and its developing public-equity market. The company remained an independently identified listed pharmaceutical business until a later consolidation of Ghana's domestic drug-manufacturing industry. By January 2020, Starwin Products Limited had merged with Dannex Limited and Ayrton Drug Manufacturing Limited. The three businesses combined under DAS Pharma, which was listed on the Ghana Stock Exchange. The merger ended Starwin's separate listed-company status and represents the latest major corporate event documented in the supplied references. Public information is insufficient to determine whether the Starwin name continued as an active consumer-facing product brand after the merger.

• 2020

  Merger into DAS Pharma

  [1]Starwin Productsen.wikipedia.org

  Starwin Products Limited merged with Dannex Limited and Ayrton Drug Manufacturing Limited to form DAS Pharma.

• 2004

  Conversion to a public limited liability company

  [1]Starwin Productsen.wikipedia.org

  Starwin became a public limited liability company on January 13, 2004.

• 2004

  Ghana Stock Exchange listing

  [1]Starwin Productsen.wikipedia.org

  Starwin was listed on the Ghana Stock Exchange in December and became part of the GSE All-Share Index.

• 1987

  Sterling Products International is acquired by Kodak

  [1]Starwin Productsen.wikipedia.org

  Following Kodak's acquisition of Sterling Products International, Starwin Products emerged under its own corporate identity.

• 1976

  Local ownership increases under Ghana's indigenization program

  [1]Starwin Productsen.wikipedia.org

  Fifty percent of the company's stock was sold to Ghanaian entrepreneurs.

• 1960

  Ghana branch of Sterling Products International begins operations

  [1]Starwin Productsen.wikipedia.org

  Starwin's business began as the Ghanaian branch of Sterling Products International.

A Ghanaian domestic pharmaceutical manufacturer focused on branded medicines and over-the-counter health products, with historical importance as the first pharmaceutical company listed on the Ghana Stock Exchange.

• Branded pharmaceutical medicine

  Rapinol

  Rapinol was one of the named branded medicines in Starwin Products' portfolio. The supplied references do not specify its active ingredients, therapeutic indication, formulation, launch date, or current availability.

• Branded pharmaceutical medicine

  Asmadrin

  Asmadrin was identified as one of Starwin's branded pharmaceutical products. Available source material does not provide detailed product information or establish whether the product continued after Starwin's merger into DAS Pharma.

• Pain-relief medicine

  Painoff

  Painoff was a named Starwin product associated with the company's branded medicine portfolio. The supplied sources do not document its formulation, dosage forms, marketing history, or post-merger status.

• Branded pharmaceutical medicine

  Paraking

  Paraking appeared among the branded products manufactured by Starwin Products. No further product specifications, launch information, or evidence of continued independent branding are provided in the available references.

• Gastrointestinal preparation

  Milk of magnesia

  Starwin's product line included milk of magnesia, a pharmaceutical preparation commonly associated with gastrointestinal use. The available material does not identify the precise formulation, packaging, or distribution history of Starwin's version.

• Over-the-counter pharmaceutical preparation

  Liver salts

  Liver salts were listed among Starwin Products' offerings. The supplied references provide no additional information about the product's formulation, claims, or period of sale.

• 2020

  Merger with Dannex and Ayrton Drug ManufacturingM&A

  Background

  Three domestic Ghanaian pharmaceutical companies consolidated their operations and public-market presence.

  Action taken

  Starwin Products Limited merged with Dannex Limited and Ayrton Drug Manufacturing Limited to form DAS Pharma.

  Aftermath

  DAS Pharma became the listed combined entity, ending Starwin's independent corporate identity as a separately listed company.

  Source

• 2004

  Conversion to public-company status and stock-market listingStrategy

  Background

  Starwin was preparing to operate as a publicly traded Ghanaian pharmaceutical manufacturer.

  Action taken

  The company became a public limited liability company in January and was listed on the Ghana Stock Exchange in December 2004.

  Aftermath

  The listing made Starwin the first pharmaceutical company on the Ghana Stock Exchange and placed it in the GSE All-Share Index.

  Source

1. 1Starwin Productsen.wikipedia.org